CanTx, Inc.
http://
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From CanTx, Inc.
Novogen Taps ASX Facility To Take Leads Into Cancer Trials
Australia’s Novogen taps the ASX OnMarket facility for funds to take its lead cancer drugs into clinical trials.
Oncology Leads Start-Up Biopharma Licensing In 2013
In our annual review of start-up dealmaking, we find again that licensed cancer products represented the bulk of alliances. Nonprofits sourced many of these oncology assets.
Life Science Start-Ups: Tech Transfer Deals, December 2013
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Tech Transfer Deals column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced October through November 2013.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice